STAQ Pharma, Inc. recalls Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42n…

Recall date

October 9, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0023-2026

FDA classification

Class III

Brand / firm

STAQ Pharma, Inc.

Sold / distributed

Nationwide in the U.S.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.